AKHMADIEV, N.S.,
AKHMETOVA, V.R.,
IBRAGIMOV, A.G.,
GALIMOVA, A.M.,
GALIMOVA, R.A.,
AGLETDINOV, E.F.,
KATAEV, V.A.,
KHAIRULLINA, V.R. (2019) ,S-palladaheterocycle, inhibition of cytochromes P450 has been modeled by
molecular docking of four palladaheterocycle stereoisomers
MENG, X.,
DUAN, C.,
PANG, H.,
CHEN, Q.,
HAN, B.,
MAGAFUROV, D.A.,
WU, P.,
LI, Z.,
ZHAO, S.,
WANG, R.,
LIN, L.,
JIANG, C.,
CAI, J.,
ZHA, C. (2019) needs further investigation. This study aims to characterize the clinical and
molecular features
identifying the phenotype of TAMs and the corresponding
molecular biomarkers can predict the aggressiveness